TREPROSTINIL
Generic: TREPROSTINIL
Alembic Pharmaceuticals Inc.Manufacturer
INTRAVENOUS, SUBCUTANEOUSRoute
TREPROSTINILActive Substance
2021-02-11Original Approval
TREPROSTINIL is FDA application ANDA211574, sponsored by ALEMBIC GLOBAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DYSPNOEA
1,414 reports
2
HEADACHE
1,238 reports
3
DIARRHOEA
1,120 reports
4
NAUSEA
946 reports
5
FATIGUE
769 reports
6
DIZZINESS
671 reports
7
COUGH
628 reports
8
HYPOTENSION
560 reports
9
DEATH
558 reports
10
VOMITING
522 reports